IL1B and Parkinson disease: A case–control study that included 67 PD patients compared to 24 healthy controls showed that plasma levels of α-synuclein, NLRP3 inflammasome, caspase-1, and IL-1β increased in PD patients compared to healthy patients controls (Fan et al. 2020).